A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors
2013 ◽
Vol 32
(1)
◽
pp. 87-93
◽
Keyword(s):
2015 ◽
Vol 33
(15_suppl)
◽
pp. 2513-2513
◽
Keyword(s):
2015 ◽
Vol 33
(15_suppl)
◽
pp. TPS2623-TPS2623
◽
Keyword(s):
2015 ◽
Vol 33
(15_suppl)
◽
pp. 3017-3017
◽
Keyword(s):